| Insider Name | Current Shares | Net Change (1yr) | Buy/Sell Ratio |
|---|---|---|---|
| Capital Partners I, LLC Bindley | 10,569,491 | +8,629,674 | 3.42 |
| WILLIAM E BINDLEY | 10,569,491 | +8,629,674 | 3.42 |
| Thomas J Jr Salentine | 10,569,491 | +8,629,674 | 3.42 |
| Investors, LLC Pharmacy | 2,449,867 | +2,000,243 | 3.42 |
| John Ackerman | 2,449,867 | +2,000,243 | 3.42 |
| Fred Burke | 2,139,239 | +1,801,220 | 3.98 |
| Kendall Forbes | 1,061,826 | +907,920 | 3.68 |
| David K Morris | 896,341 | +1,154,835 | 7.15 |
| Equity Fund, L.P. Cardinal | 816,180 | +666,386 | 3.42 |
| STEVEN D COSLER | 24,984 | +3,370 | ∞ |
| Mary Sue Patchett | 11,043 | 0 | - |
| RANDALL J LEWIS | 11,043 | 0 | - |
| Insider | Filing Date | Transaction | Shares | Change | Price | Value |
|---|---|---|---|---|---|---|
| Equity Fund, L.P. Cardinal | Mar 31 |
Option Exercise/Conversion (M)
Compensation/Award
|
816,180 | +471,057 | $0.00 | +$0 |
| Investors, LLC Pharmacy | Mar 31 |
Option Exercise/Conversion (M)
Compensation/Award
|
2,449,867 | +1,413,939 | $0.00 | +$0 |
| Fred Burke | Mar 31 |
Option Exercise/Conversion (M)
Compensation/Award
|
2,139,239 | +1,298,826 | $0.00 | +$0 |
| John Ackerman | Mar 31 |
Option Exercise/Conversion (M)
Compensation/Award
|
2,449,867 | +1,413,939 | $0.00 | +$0 |
| Capital Partners I, LLC Bindley | Mar 31 |
Option Exercise/Conversion (M)
Compensation/Award
|
10,569,491 | +6,100,175 | $0.00 | +$0 |
| David K Morris | Mar 31 |
Option Exercise/Conversion (M)
Compensation/Award
|
896,341 | +641,869 | $0.00 | +$0 |
| Kendall Forbes | Mar 31 |
Option Exercise/Conversion (M)
Compensation/Award
|
1,061,826 | +608,570 | $0.00 | +$0 |
| Thomas J Jr Salentine | Mar 31 |
Option Exercise/Conversion (M)
Compensation/Award
|
10,569,491 | +6,100,175 | $0.00 | +$0 |
| WILLIAM E BINDLEY | Mar 31 |
Option Exercise/Conversion (M)
Compensation/Award
|
10,569,491 | +6,100,175 | $0.00 | +$0 |
| Insider | Filing Date | Transaction | Shares | Change | Price | Value |
|---|---|---|---|---|---|---|
| Equity Fund, L.P. Cardinal | Mar 24 |
Open Market Sale (S)
Market Sale
|
345,123 | -275,728 | $29.68 | -$8,184,296 |
| Kendall Forbes | Mar 24 |
Open Market Sale (S)
Market Sale
|
453,256 | -346,672 | $29.68 | -$10,290,091 |
| WILLIAM E BINDLEY | Mar 24 |
Open Market Sale (S)
Market Sale
|
4,469,316 | -3,570,677 | $29.68 | -$105,986,620 |
| John Ackerman | Mar 24 |
Open Market Sale (S)
Market Sale
|
1,035,928 | -827,636 | $29.68 | -$24,566,305 |
| Capital Partners I, LLC Bindley | Mar 24 |
Open Market Sale (S)
Market Sale
|
4,469,316 | -3,570,677 | $29.68 | -$105,986,620 |
| Thomas J Jr Salentine | Mar 24 |
Open Market Sale (S)
Market Sale
|
4,469,316 | -3,570,677 | $29.68 | -$105,986,620 |
| Fred Burke | Mar 24 |
Open Market Sale (S)
Market Sale
|
840,413 | -671,432 | $29.68 | -$19,929,780 |
| Investors, LLC Pharmacy | Mar 24 |
Open Market Sale (S)
Market Sale
|
1,035,928 | -827,636 | $29.68 | -$24,566,305 |
| David K Morris | Mar 24 |
Open Market Sale (S)
Market Sale
|
254,472 | -187,855 | $29.68 | -$5,576,006 |
| Insider | Filing Date | Transaction | Shares | Change | Price | Value |
|---|---|---|---|---|---|---|
| Kendall Forbes | Mar 03 |
Grant/Award Acquisition (A)
Compensation/Award
|
799,928 | +8,952 | $0.00 | +$0 |
| David K Morris | Mar 03 |
Grant/Award Acquisition (A)
Compensation/Award
|
442,327 | +8,952 | $0.00 | +$0 |
Loading...